<strong>Progress <strong>on the Neuroprotective Effects of Estrogen</strong></strong>

Abstract

Abstract:In the past few years, there has been a growing interest in the neuroprotective effects of estrogen. An increasing amount of data suggest a neuroprotective role for estrogen; however, the molecular mechanisms whereby estrogen exerts these actions are unclear. In this review, we summarized the data supporting neuroprotection and the potential mechanisms that may contribute to these neuroprotective effects, including classical estrogen receptor activity, activation of the MAPK signaling transduction pathways, attenuation of glutamate receptor activation, antioxidant activity and regulation of mitochondrial function. Estrogen is a multi-faceted hormone modulating many aspects of neuronal function and no single mechanism of action has been elucidated for the neuroprotective effects of estrogens.

Key words:estrogen,neuroprotective,estrogen receptor (ER),neurodegenerative diseases

CLC Number:

R964

SHEN Li-xia, ZHANG Li.Progresson the Neuroprotective Effects of Estrogen[J]. Acta Neuropharmacologica, 2012, 2(3): 29-36.

References

[1] G G Kuiper, E Enmark, M Pelto-Huikko, et al. Cloning of a novel receptor expressed in rat prostate and ovary [J]. Proc Natl Acad Sci USA, 1996, 93(12): 5925-5930.

[2] Sietse Mosselman, Jan Polman, Rein Dijkema. ER beta: identification and characterization of a novel human estrogen receptor [J]. FEBS Lett, 1996, 392(1): 49-53.

[3]An Jin-ping, Ralff C J Ribeiro, Paul Webb, et al. Estradiol repression of tumor necrosis factor- alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators [J]. Proc Natl Acad Sci USA, 1999, 96(26): 15161-15166.

[4] Graeme A Scobie, Sheila Macpherson, Michael R Millar, et al. Human oestrogen receptors: differential expression of ER alpha and beta and the identification of ER beta variants [J]. Steroids, 2002, 67(2): 985-992.

[5] Shuji Hirata, Tomoko Shoda, Junzo Kato, et al. Isoform/variant mRNAs for sex steroid hormone receptors in humans[J]. Trends Endocrinol Metab, 2003, 14(3):124-129.

[6] Birgit Stoffel-Wagner. Neurosteroid biosynthesis in the human brain and its clinical implications [J]. Ann N Y Acad Sci, 2003, 1007: 64-78.

[7] Daniel Garcia-Ovejero, Inigo Azcoitia, Lydia L Doncarlos, et al. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones[J]. Brain Res Brain Res Rev, 2005, 48(2): 273-286.

[8] Patricia Rivera, Margarita Pérez-Martín, Francisco J Pavón, et al. Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus [J]. PLoS One, 2013, 8(5): e64750.

[9] Chrystelle Ibanez, Rachida Guennoun, Philippe Liere, et al. Developmental expression of genes involved in neurosteroidogenesis: 3beta-hydroxysteroid dehydrogenase /delta5-delta4 isomerase in the rat brain [J]. Endocrinology, 2003, 144(7): 2902-2911.

[10] Yasushi Hojo, Taka-aki Hattori, Taihei Enami, et al. Adult male rat hippocampus synthesizes estradiol from pregnanolone by cytochromes P45017alpha and P450 aromatase localized in neurons[J]. Proc Natl Acad Sci USA, 2004, 101(3): 865-870.

[11]Brinton R D, Tran J, Proffitt P, et al. 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture[J]. Neurochem Res, 1997, 22(11): 1339-1351.

[12] Erin Scott, Zhang Quan-Guang, Wang Rui-min, et al. Estrogen neuroprotection and the critical period hypothesis[J]. Front Neuroendocrinol, 2012, 33(1): 85-104.

[13]Yang Shao-Hua, Shi Jiong, Arthur L Day , et al. Estradiol exerts neuroprotective effects when administered after ischemic insult[J]. Stroke, 2000, 31(3): 745-749.

[14]Wang Qiong, Roberto Santizo, Vernal L Baughman, et al. Estrogen provides neuroprotection in transient forebrainischemia through perfusion-independent mechanisms in rats [J]. Stroke, 1999, 30(3): 630-637.

[15]Victor W. Henderson. Aging, estrogens, and episodic memory in women[J]. Cogn Behav Neurol, 2009, 22(4): 205-214.

[16] Sarah C Janicki, Nicole Schupf. Hormonal influences on cognition and risk for Alzheimer’s disease [J]. Curr Neurol Neurosci Rep, 2010, 10(5):359-366.

[17]Shao H, Breitner J C, Whitmer R A, et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study[J]. Neurology, 2012, 79 (18): 1846-1852.

[18]Hu Ling, Yue Yun, Zuo Ping-Ping, et al. Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner [J]. Chin Med Sci J, 2006, 21(4): 214-218.

[19] Sally E Shaywitz, Bennett A Shaywitz, Kenneth R Pugh, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks[J]. JAMA, 1999, 281(13): 1197-1202.

[20] Victor W Henderson. Cognitive changes after menopause: influence of estrogen[J]. Clin Obstet Gynecol 2008,51(3):618-626.

[21] Jae H Kang, Jennifer Weuve, Francine Grodstein. Postmenopausal hormone therapy and risk of cognitive decline in communitydwelling aging women [J]. Neurology, 2004, 63(1): 101-107.

[22] Violetta Dziedziejko, Monika Bia?ecka, Anna Machoy-Mokrzyńska, et al. The role of estrogens in Parkin- son's disease [J]. Postepy Hig Med Dosw, 2009, 63: 627-633.

[23]Shao Bei, Cheng Yi-fan, Jin Kun-lin, et al. Estrogen, neuroprotection and neurogenesis after ischemic stroke [J]. Curr Drug Targets, 2012, 13(2):188-198.

[24] J M Pavon, H E Whitson, M S Okun. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research [J]. Maturitas, 2010, 65(4): 352-358.

[25] Kathrine Rugbjerg, Jane Christensen, Anne Tjønneland, et al. Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark [J]. Parkinsonism Relat Disord, 2013, 19(4): 457-60.

[26] Ana I Rodriguez-Perez, Antonio Dominguez-Meijide, Jose L Lanciego, et al. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease[J]. Neurobiol Dis, 2013, 58(14): 209-219.

[27] Koji Osuka, Paul J Feustel, Alexander A Mongin, et al. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat[J]. J Neurochem, 2001, 76(6): 1842-1850.

[28] Shyamal H Mehta, K M Dhandapani, L M De Sevilla, et al. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat [J]. Neuroendocrinology, 2003, 77(1): 44-50.

[29] Teresa A Milner, Kehinde Ayoola, Carrie T Drake, et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation [J]. J Comp Neurol, 2005, 491(2): 81–95.

[30] Dean P Edwards. Regulation of signal transduction pathways by estrogen and progesterone [J]. Annu Rev Physiol, 2005, 67: 335–376.

[31] Claudia C Aguirre, Michel Baudry. Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices [J]. Eur J Neurosci, 2009, 29(3): 447-454.

[32] M Singh, C Su. Progesterone, brain-derived neurotrophic factor and neuro-protection [J].Neuroscience, 2013, 239: 84-91.

[33] Lu Fan, Subhash C Pandey, Rochelle S Cohen, et al. Estrogen affects levels of Bcl-2 protein and mRNA in medial amygdala of ovariectomized rats [J]. J Neurosci Res, 2008, 86(16): 3655-3664.

[34] Andrea Cardona-Rossinyol, Margalida Mir, Victor Caraballo-Miralles, et al. Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants [J]. Cell Mol Neurobiol, 2013, 33(3):421-432.

[35] Bernd Moosmann, Christian Behl . The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties[J]. Proc Natl Acad Sci USA, 1999, 96(16): 8867-8872.

[36] Cibele Canal Castro , Aline S Pagnussat , Lenir Orlandi , et al. Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats[J]. Brain Res, 2012, 1474: 82-90.

[37] Lakshmi Gollalpudi, Monica M Oblinger. Estrogen and NGF synergistically protect terminally differentiated, ERa-transfected PC-12 cells from apoptosis [J]. J Neurosci Res, 1999, 56(5): 471-481.

[38] Kenji Shimada, Keiko T Kitazato, Tomoya Kinouchi , et al. Activation of estrogen receptor-α and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats[J]. Hypertension, 2011, 57(6): 1161-1166.

[39] Ling Wang, Sandra Andersson, Margaret Warner, et al. Morphological abnormalities in the brains of estrogen receptorbeta knockout mice [J]. Proc Natl Acad Sci USA, 2001, 98(5): 2792–2796.

[40] Christina M Doolan, Steven B Condliffe, Brian J Harvey. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and Ca(2+)(i) by 17beta-oestradiol in female rat distal colon[J]. Br J Pharmacol, 2000, 129(7): 1375-1386.

[41]Tian Zhen, Wang Yu, Zhang Nan, et al. Estrogen receptor GPR30 exerts anxiolytic effects by maintaining the balance between GABAergic and glutamatergic transmission in the basolateral amygdala of ovariectomized mice after stress[J]. Psychoneuro-endocrinology, 2013, 38(10): 2218-2233.

[42]Liu Shui-Bing, Zhao Ming-Gao. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors [J]. Brain Res Bull, 2013, 93: 27-31.

[43] Yadong Goodman, Annadora J Bruce, Bruce Cheng. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons [J]. J Neurochem, 1996, 66(5): 1836-1844.

[44] Raymond F Regan, Yaping Guo. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures [J]. Brain Res, 1997, 764(1-2): 1333-1340.

[45] Christian Behl, Thomas Skutella, Frank Lezoualc'h, et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship[J]. Mol Pharmacol, 1997, 51(4): 535-541.

[46] Adrian Roth, Willy Schaffner, Cornelia Hertel. Phytoestrogen kaempferol (3,4',5,7- tetra- hydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity[J]. J Neurosci Res, 1999, 57(3): 399-404.

[47] Eunsook Lee, Marta Sidoryk-Wegrzynowicz, Marcelo Farina, et al. Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytes [J]. Neurotox Res, 2013, 23(2): 124-130.

[48]De Marinis E, Acaz-Fonseca E, M A Arevalo, et al. 17β-Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor β-mediated neuroglobin up-regulation [J]. J Neuroendocrinol, 2013, 25(3): 260-270.

[49] P S Green, K E Gridley, J W Simpkins. Nuclear estrogen receptor-independent neuroprotection by estratrienes: anovel interaction with glutathione [J]. Neuroscience, 1998, 84(1): 7-10.

[50] Yasutomi Kuroki, Kouji Fukushima, Yasunari Kanda, et al. Neuroprotection by estrogen via extracellular signalregulated kinase against quinolinic acid-induced cell death in the rat hippocampus [J]. Eur J Neurosci, 2000, 13(3): 472–476.

[51] Meharvan Singh, Gyorgy SétálóJr, Xiaoping Guan, et al. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways[J]. J Neurosci, 1999, 19(4): 1179-1188.

[52] Paramjit Kaur, Parmeet K Jodhka, Wendy A Underwood, et al. Progesterone increases brain-derived neurotrophic factor expression and protects against glutamate toxicity in a mitogen- activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants [J]. J Neurosci Res, 2007, 85(11): 2441-2449.

[53] Jyoti J Watters, Jean S Campbell, Matthew J Cunningham, et al. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen actived protein kinase signalling cascade and c-fos immediate early gene transcription[J]. Endocrinology, 1997, 138(9): 4030-4033.

[54] C D Toran-Allerand. Novel sites and mechanisms of oestrogen action in the brain [J]. Novartis Found Symp, 2000, 230:56-69.

[55] J A VanderKuur, T Wiese, S C Brooks. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex [J]. Biochem, 1993, 32(27): 7002- 7008.

[56] Cherie A Singer, Xavier A Figueroa-Masot, Robert H Batchelor, et al. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons [J]. J Neurosci, 1999, 19(7): 2455-2463.

[57] Pattie S Green, Jean Bishop, James W Simpkins. 17 alpha-estradiol exerts neuroprotective effects in SK-N-SH cells [J]. J Neurosci, 1997, 17(2): 511-515.

[58] Pattie S Green, Kelly E Gridley, James W Simpkins. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH cells [J]. Neurosci Lett, 1996, 218(3): 165-168.

[59] Arjun L Khandare, M Ankulu, N Aparna. Role of glutamate and nitric oxide in onset of motor neuron degeneration in neurolathyrism [J]. Neurotoxicology, 2013, 34: 269-274.

[60] Polina A Abushik, Dmitry A Sibarov, Misty J Eaton, et al. Kainate-induced calcium overload of cortical neurons in vitro: Dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain[J]. Cell Calcium, 2013, 54(2): 95-104.

[61] Saumyendra N Sarkar, Huang Ren-Qi, Shaun M Logan, et al. Estrogens directly potentiate neuronal L-type Ca2+ channels [J]. Proc Natl Acad Sci USA, 2008, 105(39): 15148-15153.

[62] Charles E Weaver Jr, Mijeong Park-Chung, Terrell T Gibbs, et al. 17beta-Estradiol protects against NMDA- induced excitotoxicity by direct inhibition of NMDA receptors[J]. Brain Res, 1997, 761 (2): 338-341.

[63] Catherine S Woolley, Nancy G Weiland, Bruce S McEwen, et al. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density [J]. J Neurosci, 1997, 17(5): 1848-1859.

[64] L Zhao, S Chen, J Ming Wang, et al. 17beta-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism[J]. Neuroscience, 2005, 132(2): 299-311.

[65] Nader Shahrokhi, Mohammad Khaksari Haddad, Siavash Joukar, et al. Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury [J]. Pak J Pharm Sci, 2012, 25(1): 219-225.

[66]Yang Shao-Hua, He Zhen, Samuel S Wu, et al. 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage [J]. J Cereb Blood Flow Metab, 2001, 21(2): 174-181.

[67] Abhi K Rao, Alicia K Dietrich, Yvonne S Ziegler, et al. 17β-Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia [J]. J Steroid Biochem Mol Biol, 2011, 127(3-5): 382-389.

[68] M Lagouge, N-G Larsson. The role of mitochondrial DNA mutations and free radicals in disease and ageing [J]. J Intern Med, 2013, 273(6): 529-543.

[69] Daniele Orsucci, Michelangelo Mancuso, Elena C Ienco, et al. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease [J]. Curr Neurovasc Res, 2013, 10 (1): 76-80.

[70]Zheng Jian-biao, Victor D Ramirez. Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase[J]. J Steroid Biochem Mol Biol, 1999, 68(1-2): 65-75.

[71] Matteo Suman, Marta Giacomello, Livio Corain, et al. Estradiol effects on intracellular Ca(2+) homeostasis in bovine brain-derived endothelial cells[J]. Cell Tissue Res, 2012, 350(1): 109-118.

[72] M P Mattson, N Robinson, Q Guo. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1[J]. Neuroreport, 1997, 8(17): 3817-3821.

[73] Paul J Shughrue. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ER alpha and ER beta) [J]. Exp Neurol, 2004, 190(2): 468–477.

[74] Consuelo Borrás, Juan Gambini, Ma Carmen Gómez-Cabrera, et al. 17beta-oestradiol up-regulates longevity- related, antioxidant enzyme expression via the ERK1 and ERK2 (MAPK)/NFkappa B cascade[J]. Aging Cell, 2005, 4(3): 113-118.

[75]Alonso A, Gonzalez C. Neuroprotective role of estrogens: relationship with insulin/IGF-1 signaling [J]. Front Biosci, 2012, 4: 607-619.

[76] P Luciani, C Deledda, S Benvenuti, et al. Relationship between the neuroprotective effects of insulin-like growth factor-1 and 17β-oestradiol in human neuroblasts[J]. J Neuroendocrinol, 2012, 24(10): 1304-1310.

[77]Guo Jia-bin, Sue P Duckles, John H Weiss, et al. 17β-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion [J]. Free Radic Biol Med, 2012, 52(11-12): 2151-2160.

[78] Maria D Ganfornina, Sonia Do Carmo, Eva Martinez, et al. Apo D, a glia-derived apolipo- protein, is required for peripheral nerve functional integrity and a timely response to injury [J]. Glia, 2010, 58(11): 1320-1334.

[79] Cristina Pérez, Ana Navarro, Eva Martínez, et al. Age-related changes of apolipo- protein D expression in female rat central nervous system with chronic estradiol treatment [J].Age, 2012, 34 (4): 895-904.

Progresson the Neuroprotective Effects of Estrogen

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64.
[2]	ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46.
[3]	YANG-Lin，AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64.
[4]	SHEN li-xia1，LIU Liang-liang1，ZHANG Ming1，LIU Yang1，ZHANG Dan-shen 2*.Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms[J]. Acta Neuropharmacologica, 2018, 8(4): 23-25.
[5]	WANG Cui, GUO Tong-lin, SHEN Li-xia.Study on the Neuroprotective Effects of Phytoestrogens in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2017, 7(4): 43-52.
[6]	HU Bao-ling, GUO Chun-yan.Advances Achievements about Neuroprotective Mechanisms of Paeoniflorin[J]. Acta Neuropharmacologica, 2015, 5(6): 51-56.
[7]	LIU Yang, SHEN Li-Xia.Research Progress of Estrogen Signal Pathway in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2015, 5(4): 43-54.
[8]	ZHONG Ming, SHEN Li-Xia.Study of the Mechanism of Estrogen on Neuroprotective Effect[J]. Acta Neuropharmacologica, 2015, 5(2): 54-64.
[9]	TIAN Hui，ZHANG Dan-shen.Progress on the Neuroprotective Mechanism of Gastrodin[J]. Acta Neuropharmacologica, 2013, 3(5): 58-64.
[10]	LIU Liang-jing, SHEN Li-xia.An Update on Neuroprotective Effects of Estrogen in Alzheimer's Disease[J]. Acta Neuropharmacologica, 2013, 3(4): 58-64.
[11]	LIU Ting-ting, SUN Fang-ling, AI Hou-xi, ZHANG Li, WANG Wen.Effects of Morroniside on the expression of CyclinD1 and Cdk6 in Hippocampus of Rats with Focal Cerebral Ischemia/Reperfusion Injury[J]. Acta Neuropharmacologica, 2013, 3(4): 1-7.
[12]	MA Xin-zhe,LV Yang，WANG Hai-ping.A Review on the Relationship between Estrogen, Estrogen Receptor and Hypertension Disease[J]. Acta Neuropharmacologica, 2013, 3(3): 34-38.
[13]	LI Zeng-fang,HE Xiao-li,BI Ming-gang.Effects of Tamoxifen on Learning and Memory in Female Rats[J]. Acta Neuropharmacologica, 2013, 3(3): 1-7.
[14]	XIAO Han-ping1, WANG Shuo-yu2, LI Hua-nan2, ZHANG Shui-yin1, GU Bing1.Pharmacotherapies for Spinal Cord Injury: Current Status[J]. Acta Neuropharmacologica, 2012, 2(2): 32-36.
[15]	ZHAO Li-yan1，YU Xiu-juan1，HAN Tian-yun2，ZHANG Wan-ming1.A Review on the Neuroprotective Effects of Curcumin[J]. Acta Neuropharmacologica, 2012, 2(2): 58-64.